AngioDynamics (ANGO) Reports In-Line Q2 EPS, Miss on Revenues; Lowers FY18 Revenue Guidance Below Consensus
Go back to AngioDynamics (ANGO) Reports In-Line Q2 EPS, Miss on Revenues; Lowers FY18 Revenue Guidance Below Consensus| AngioDynamics, Inc. (NASDAQ: ANGO) | Delayed: 15.66 -0.09 (0.57%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $15.75 | 52 Week High | $17.64 | |||
| Open | $15.97 | 52 Week Low | $9.71 | |||
| Day High | $16.04 | P/E | N/A | |||
| Day Low | $15.45 | EPS | $-0.07 | |||
| Volume | 409,373 | |||||
